Self-Motivation
David Goggins
Former Navy Seal
Career Development
Bryan Cranston
Actor
Critical Thinking
Liv Boeree
International Poker Champion
Emotional Intelligence
Amaryllis Fox
Former CIA Clandestine Operative
Management
Chris Hadfield
Retired Canadian Astronaut & Author
Learn
from the world's big
thinkers
Start Learning

New therapy turns cancer cells into fat to stop it from spreading

Researchers at the University of Basel in Switzerland have hijacked cancer's cellular plasticity to turn the disease against itself.

Photo credit: BEHROUZ MEHRI / AFP / Getty Images
  • In 2018, an estimated 627,000 women died from breast cancer worldwide.
  • Researchers recently discovered a drug combination that turned cancer cells into fat cells, preventing its proliferation.
  • The drug therapy could be used to halt metastasis, the leading cause of death from cancer.

It may be a family member, a friend, a coworker, or even yourself, but chances are breast cancer will invade your life at some point. According to the Center for Disease Control and Prevention, 242,476 new cases of female breast cancer were reported in 2015 alone. The disease took the lives of 41,523 women that same year. This makes breast cancer the most commonly diagnosed cancer, and the second leading cause of cancer deaths among American women.

Worldwide, cancers represent the second leading cause of death, surpassed only by heart disease. Yet despite these disheartening numbers, we are making progress in developing effective treatments against this deadly affliction.

Scientists may have given us another tool to further this progress. They've developed a new drug therapy that prevents malignant cancer growth. How? By turning cancer cells into fat.

The good kind of fat

Low magnification micrograph of a metastatic tumor [left side] in the ovary. This tumor metastasized from a tumor in the woman's breast. Photo credit: Wikimedia Commons

Metastasis is the leading cause of death from cancer, occurring when cancer cells separate from the original tumor to proliferate elsewhere. These new cancer cells travel through the bloodstream or lymphatic system. Since these bodily systems are thoroughly connected, cancer can spread to a variety of locations. Breast cancer, for example, "tends to spread to the bones, liver, lungs, chest wall, and brain."

Cancer cell plasticity — an ability that allows cancer cells to shift physiological characteristics dramatically — fosters metastasis and is responsible for cancer's resistance to treatments. To combat its resistance, researchers at the University of Basel in Switzerland decided to turn cancer's cellular plasticity against itself. They used Rosiglitazone, an anti-diabetic drug, along with MEK inhibitors in mice implanted with breast cancer cells. Their aim was to alter the cancer cells.

The drug combination hijacked the breast cancer cells during epithelial-mesenchymal transition (EMT), a process by which the cells undergo biochemical changes. EMT plays a role in many bodily functions, such as tissue repair. In unaltered cancer cells, EMT allows them to migrate away from the original tumor while maintaining their oncogenic properties.

But in cancer cells assaulted by the new drug therapy, EMT changes them into adipocytes, or fat cells. Like normal fat cells, these former breast cancer cells were both functional and post-mitotic, meaning they could no longer divide and proliferate.

While the therapy did not alter the original tumor, it did prevent new cancer cells from dividing and spreading elsewhere in the body. This repressed metastasis in the researcher's preclinical trials.

The researchers published their findings on January 14 in the journal Cancer Cell.

"In future, this innovative therapeutic approach could be used in combination with conventional chemotherapy to suppress both primary tumor growth and the formation of deadly metastases," senior study author Gerhard Christofori told Medical News Today.

Since the research used FDA-approved drugs to study the treatment's effects, the study notes, "a clinical translation may be possible."

Will we win the battle against cancer?

Members of Lebanon's Ladies of Harley hold placards as take part in an event organised by Pink Steps Lebanon to raise awareness about breast cancer on October 28, 2018. Photo credit: MAHMOUD ZAYYAT / AFP / Getty Images

This article opened with some fearful figures about cancer and its effect on people worldwide. But there's reason to hope.

While the total number of new cancer cases and deaths continues to increase, the rates of cancer diagnoses and deaths decline each year — as absolute figures don't account for rises in life expectancy, population growth, or aging populations. We've made great strides in understanding the disease and its various genetic and environmental origins. And events like Breast Cancer Awareness Month continue to educate the populace about the preventative measures available to them.

Thanks to scientists like those at the University of Basel in Switzerland, we may have more reasons to be hopeful very soon.

Neom, Saudi Arabia's $500 billion megacity, reaches its next phase

Construction of the $500 billion dollar tech city-state of the future is moving ahead.

Credit: Neom
Technology & Innovation
  • The futuristic megacity Neom is being built in Saudi Arabia.
  • The city will be fully automated, leading in health, education and quality of life.
  • It will feature an artificial moon, cloud seeding, robotic gladiators and flying taxis.
Keep reading Show less

Why do people believe in conspiracy theories?

Are we genetically inclined for superstition or just fearful of the truth?

Videos
  • From secret societies to faked moon landings, one thing that humanity seems to have an endless supply of is conspiracy theories. In this compilation, physicist Michio Kaku, science communicator Bill Nye, psychologist Sarah Rose Cavanagh, skeptic Michael Shermer, and actor and playwright John Cameron Mitchell consider the nature of truth and why some groups believe the things they do.
  • "I think there's a gene for superstition, a gene for hearsay, a gene for magic, a gene for magical thinking," argues Kaku. The theoretical physicist says that science goes against "natural thinking," and that the superstition gene persists because, one out of ten times, it actually worked and saved us.
  • Other theories shared include the idea of cognitive dissonance, the dangerous power of fear to inhibit critical thinking, and Hollywood's romanticization of conspiracies. Because conspiracy theories are so diverse and multifaceted, combating them has not been an easy task for science.

COVID-19 brain study to explore long-term effects of the virus

A growing body of research suggests COVID-19 can cause serious neurological problems.

Brain images of a patient with acute demyelinating encephalomyelitis.

Coronavirus
  • The new study seeks to track the health of 50,000 people who have tested positive for COVID-19.
  • The study aims to explore whether the disease causes cognitive impairment and other conditions.
  • Recent research suggests that COVID-19 can, directly or indirectly, cause brain dysfunction, strokes, nerve damage and other neurological problems.
Keep reading Show less
Sponsored by Charles Koch Foundation

Better reskilling can future-proof jobs in the age of automation. Enter SkillUp's new coalition.

Coronavirus layoffs are a glimpse into our automated future. We need to build better education opportunities now so Americans can find work in the economy of tomorrow.

Scroll down to load more…
Quantcast